Pat Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, and Executive Chairman of the Los Angeles Times, shared a post on X:
“My meeting with President Donald J. Trump and HRH MBS in May 2025 resulted in such amazing results and action! In less than a year we received the world’s first approval for lung cancer for the Bioshield… and now we have established a wholly owned subsidiary in the Kingdom to support physicians and healthcare systems throughout the MENA region.
Distribution readiness of Anktiva for both bladder and lung cancer patients since approval just one year ago will amaze all at the speed… congratulations to our team ImmunityBio who worked tirelessly to make this happen and ensure rapid access of the Bioshield to patients in the Kingdom… stay tuned!”
Other articles about ImmunityBio on OncoDaily.